Helen Sabzevari - 12 May 2021 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role: President and CEO, Director
Signature: /s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact
Issuer symbol: PGEN
Transactions as of: 12 May 2021
Net transactions value: -$303,571
Form type: 4
Filing time: 14 May 2021, 18:43:52 UTC
Next filing: 28 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PGEN	Common Stock	Options Exercise		+97,276	+15%		752,490	12 May 2021	Direct	F1
transaction	PGEN	Common Stock	Sale	$303,571	-47,433	-6.3%	$6.40	705,057	13 May 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PGEN	Restricted Stock Units	Options Exercise	$0	-97,276	-100%	$0.000000^*	0	12 May 2021	Common Stock	97,276		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock.
F2	This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs.
F3	The RSUs were granted on March 25, 2021 and have vested in full.